Cargando…

Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin‐rich thrombus

BACKGROUND AND AIM: Portal vein thrombosis (PVT) is a common complication of cirrhosis. The exact pathophysiology remains largely unknown, and treatment with anticoagulants does not lead to recanalization of the portal vein in all patients. A better insight into the structure and composition of port...

Descripción completa

Detalles Bibliográficos
Autores principales: Driever, Ellen G., von Meijenfeldt, Fien A., Adelmeijer, Jelle, de Haas, Robbert J., van den Heuvel, Marius C., Nagasami, Chandrasekaran, Weisel, John W., Fondevila, Constantino, Porte, Robert J., Blasi, Anabel, Heaton, Nigel, Gregory, Stephen, Kane, Pauline, Bernal, William, Zen, Yoh, Lisman, Ton
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300169/
https://www.ncbi.nlm.nih.gov/pubmed/34559897
http://dx.doi.org/10.1002/hep.32169
_version_ 1784751150213365760
author Driever, Ellen G.
von Meijenfeldt, Fien A.
Adelmeijer, Jelle
de Haas, Robbert J.
van den Heuvel, Marius C.
Nagasami, Chandrasekaran
Weisel, John W.
Fondevila, Constantino
Porte, Robert J.
Blasi, Anabel
Heaton, Nigel
Gregory, Stephen
Kane, Pauline
Bernal, William
Zen, Yoh
Lisman, Ton
author_facet Driever, Ellen G.
von Meijenfeldt, Fien A.
Adelmeijer, Jelle
de Haas, Robbert J.
van den Heuvel, Marius C.
Nagasami, Chandrasekaran
Weisel, John W.
Fondevila, Constantino
Porte, Robert J.
Blasi, Anabel
Heaton, Nigel
Gregory, Stephen
Kane, Pauline
Bernal, William
Zen, Yoh
Lisman, Ton
author_sort Driever, Ellen G.
collection PubMed
description BACKGROUND AND AIM: Portal vein thrombosis (PVT) is a common complication of cirrhosis. The exact pathophysiology remains largely unknown, and treatment with anticoagulants does not lead to recanalization of the portal vein in all patients. A better insight into the structure and composition of portal vein thrombi may assist in developing strategies for the prevention and treatment of PVT. APPROACH AND RESULTS: Sixteen prospectively and 63 retrospectively collected nonmalignant portal vein thrombi from patients with cirrhosis who underwent liver transplantation were included. Histology, immunohistochemistry, and scanning electron microscopy were used to assess structure and composition of the thrombi. Most recent CT scans were reanalyzed for thrombus characteristics. Clinical characteristics were related to histological and radiological findings. All samples showed a thickened, fibrotic tunica intima. Fibrin‐rich thrombi were present on top of the fibrotic intima in 9/16 prospective cases and in 21/63 retrospective cases. A minority of the fibrotic areas stained focally positive for fibrin/fibrinogen (16% of cases), von Willebrand factor (VWF; 10%), and CD61 (platelets, 21%), while most of the fibrin‐rich areas stained positive for those markers (fibrin/fibrinogen, 100%; VWF, 77%; CD61, 100%). No associations were found between clinical characteristics including estimated thrombus age and use of anticoagulants and presence of fibrin‐rich thrombi. CONCLUSION: We demonstrate that PVT in patients with cirrhosis consists of intimal fibrosis with an additional fibrin‐rich thrombus in only one‐third of cases. We hypothesize that our observations may explain why not all portal vein thrombi in patients with cirrhosis recanalize by anticoagulant therapy.
format Online
Article
Text
id pubmed-9300169
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93001692022-07-21 Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin‐rich thrombus Driever, Ellen G. von Meijenfeldt, Fien A. Adelmeijer, Jelle de Haas, Robbert J. van den Heuvel, Marius C. Nagasami, Chandrasekaran Weisel, John W. Fondevila, Constantino Porte, Robert J. Blasi, Anabel Heaton, Nigel Gregory, Stephen Kane, Pauline Bernal, William Zen, Yoh Lisman, Ton Hepatology Original Articles BACKGROUND AND AIM: Portal vein thrombosis (PVT) is a common complication of cirrhosis. The exact pathophysiology remains largely unknown, and treatment with anticoagulants does not lead to recanalization of the portal vein in all patients. A better insight into the structure and composition of portal vein thrombi may assist in developing strategies for the prevention and treatment of PVT. APPROACH AND RESULTS: Sixteen prospectively and 63 retrospectively collected nonmalignant portal vein thrombi from patients with cirrhosis who underwent liver transplantation were included. Histology, immunohistochemistry, and scanning electron microscopy were used to assess structure and composition of the thrombi. Most recent CT scans were reanalyzed for thrombus characteristics. Clinical characteristics were related to histological and radiological findings. All samples showed a thickened, fibrotic tunica intima. Fibrin‐rich thrombi were present on top of the fibrotic intima in 9/16 prospective cases and in 21/63 retrospective cases. A minority of the fibrotic areas stained focally positive for fibrin/fibrinogen (16% of cases), von Willebrand factor (VWF; 10%), and CD61 (platelets, 21%), while most of the fibrin‐rich areas stained positive for those markers (fibrin/fibrinogen, 100%; VWF, 77%; CD61, 100%). No associations were found between clinical characteristics including estimated thrombus age and use of anticoagulants and presence of fibrin‐rich thrombi. CONCLUSION: We demonstrate that PVT in patients with cirrhosis consists of intimal fibrosis with an additional fibrin‐rich thrombus in only one‐third of cases. We hypothesize that our observations may explain why not all portal vein thrombi in patients with cirrhosis recanalize by anticoagulant therapy. John Wiley and Sons Inc. 2021-12-05 2022-04 /pmc/articles/PMC9300169/ /pubmed/34559897 http://dx.doi.org/10.1002/hep.32169 Text en © 2021 The Authors. Hepatology published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Driever, Ellen G.
von Meijenfeldt, Fien A.
Adelmeijer, Jelle
de Haas, Robbert J.
van den Heuvel, Marius C.
Nagasami, Chandrasekaran
Weisel, John W.
Fondevila, Constantino
Porte, Robert J.
Blasi, Anabel
Heaton, Nigel
Gregory, Stephen
Kane, Pauline
Bernal, William
Zen, Yoh
Lisman, Ton
Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin‐rich thrombus
title Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin‐rich thrombus
title_full Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin‐rich thrombus
title_fullStr Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin‐rich thrombus
title_full_unstemmed Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin‐rich thrombus
title_short Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin‐rich thrombus
title_sort nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin‐rich thrombus
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300169/
https://www.ncbi.nlm.nih.gov/pubmed/34559897
http://dx.doi.org/10.1002/hep.32169
work_keys_str_mv AT drieverelleng nonmalignantportalveinthrombiinpatientswithcirrhosisconsistofintimalfibrosiswithorwithoutafibrinrichthrombus
AT vonmeijenfeldtfiena nonmalignantportalveinthrombiinpatientswithcirrhosisconsistofintimalfibrosiswithorwithoutafibrinrichthrombus
AT adelmeijerjelle nonmalignantportalveinthrombiinpatientswithcirrhosisconsistofintimalfibrosiswithorwithoutafibrinrichthrombus
AT dehaasrobbertj nonmalignantportalveinthrombiinpatientswithcirrhosisconsistofintimalfibrosiswithorwithoutafibrinrichthrombus
AT vandenheuvelmariusc nonmalignantportalveinthrombiinpatientswithcirrhosisconsistofintimalfibrosiswithorwithoutafibrinrichthrombus
AT nagasamichandrasekaran nonmalignantportalveinthrombiinpatientswithcirrhosisconsistofintimalfibrosiswithorwithoutafibrinrichthrombus
AT weiseljohnw nonmalignantportalveinthrombiinpatientswithcirrhosisconsistofintimalfibrosiswithorwithoutafibrinrichthrombus
AT fondevilaconstantino nonmalignantportalveinthrombiinpatientswithcirrhosisconsistofintimalfibrosiswithorwithoutafibrinrichthrombus
AT porterobertj nonmalignantportalveinthrombiinpatientswithcirrhosisconsistofintimalfibrosiswithorwithoutafibrinrichthrombus
AT blasianabel nonmalignantportalveinthrombiinpatientswithcirrhosisconsistofintimalfibrosiswithorwithoutafibrinrichthrombus
AT heatonnigel nonmalignantportalveinthrombiinpatientswithcirrhosisconsistofintimalfibrosiswithorwithoutafibrinrichthrombus
AT gregorystephen nonmalignantportalveinthrombiinpatientswithcirrhosisconsistofintimalfibrosiswithorwithoutafibrinrichthrombus
AT kanepauline nonmalignantportalveinthrombiinpatientswithcirrhosisconsistofintimalfibrosiswithorwithoutafibrinrichthrombus
AT bernalwilliam nonmalignantportalveinthrombiinpatientswithcirrhosisconsistofintimalfibrosiswithorwithoutafibrinrichthrombus
AT zenyoh nonmalignantportalveinthrombiinpatientswithcirrhosisconsistofintimalfibrosiswithorwithoutafibrinrichthrombus
AT lismanton nonmalignantportalveinthrombiinpatientswithcirrhosisconsistofintimalfibrosiswithorwithoutafibrinrichthrombus